![Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis | Scientific Reports Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep08191/MediaObjects/41598_2015_Article_BFsrep08191_Fig1_HTML.jpg)
Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis | Scientific Reports
![PDF) Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma PDF) Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma](https://i1.rgstatic.net/publication/363842928_Long-term_effectiveness_and_safety_of_omalizumab_in_pediatric_and_adult_patients_with_moderate-to-severe_inadequately_controlled_allergic_asthma/links/6330f84d165ca2278770773c/largepreview.png)
PDF) Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma
![These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR® (omalizumab) injection, for subcutaneous use XOLAIR® (omalizumab) for injection, for These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR® (omalizumab) injection, for subcutaneous use XOLAIR® (omalizumab) for injection, for](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=xolair-23b.jpg&id=726081)
These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR® (omalizumab) injection, for subcutaneous use XOLAIR® (omalizumab) for injection, for
![Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance - ScienceDirect Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1323893021000010-ga1.jpg)
Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance - ScienceDirect
![Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient | Clinical and Molecular Allergy | Full Text Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient | Clinical and Molecular Allergy | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12948-019-0109-z/MediaObjects/12948_2019_109_Fig2_HTML.jpg)